Gen-Plus finishes successfully the re-qualification of its PML-installation for any types of drug products based on film technology like Oral Dispersible Films and TTS-formulations. This gives us full reach now into the Clinical Trial Sample segment which means extended services and an organizational de-complexation for our clients. We are very happy about this achievement as it completes our Center of Excellence in the derma/topical segment.

Related Posts

  • Drug Delivery Summit Frankfurt Juni 24-25

    read more

  • Gen-Plus @ BayOConnect 2024 in Munich

    read more

  • Gen Plus @ European Drug Delivery Summit

    read more